Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional Study to Assess Reaching of Cholesterol Target Values in Patients Treated With 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) Reductase Inhibitors in Croatia

NCT01257971 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01257971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01257971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional Study to Assess Reaching of Cholesterol Target Values in Patients Treated With 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) Reductase Inhibitors in Croatia
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
January 31, 2011
Completion date
October 31, 2011
Enrollment
1,868 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolaemia